DK152431C - Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive, anellerede pyrimidinderivater eller farmaceutisk acceptable salte eller optisk aktive isomere deraf - Google Patents

Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive, anellerede pyrimidinderivater eller farmaceutisk acceptable salte eller optisk aktive isomere deraf

Info

Publication number
DK152431C
DK152431C DK059177A DK59177A DK152431C DK 152431 C DK152431 C DK 152431C DK 059177 A DK059177 A DK 059177A DK 59177 A DK59177 A DK 59177A DK 152431 C DK152431 C DK 152431C
Authority
DK
Denmark
Prior art keywords
optically active
pyrimidide
originated
racemic
analogue
Prior art date
Application number
DK059177A
Other languages
Danish (da)
English (en)
Other versions
DK152431B (da
DK59177A (da
Inventor
Istvan Hermecz
Zoltan Meszaros
Sandor Virag
Lelle Vasvari
Agnes Horvath
Jozsef Knoll
Gyula Sebestyen
Agoston David
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of DK59177A publication Critical patent/DK59177A/da
Publication of DK152431B publication Critical patent/DK152431B/da
Application granted granted Critical
Publication of DK152431C publication Critical patent/DK152431C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK059177A 1976-02-12 1977-02-11 Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive, anellerede pyrimidinderivater eller farmaceutisk acceptable salte eller optisk aktive isomere deraf DK152431C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUCI001642 1976-02-12
HU76CI1642A HU174693B (hu) 1976-02-12 1976-02-12 Sposob poluchenija kondensirovannykh proizvodnykh pirimidina

Publications (3)

Publication Number Publication Date
DK59177A DK59177A (da) 1977-08-13
DK152431B DK152431B (da) 1988-02-29
DK152431C true DK152431C (da) 1988-08-01

Family

ID=10994601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK059177A DK152431C (da) 1976-02-12 1977-02-11 Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive, anellerede pyrimidinderivater eller farmaceutisk acceptable salte eller optisk aktive isomere deraf

Country Status (28)

Country Link
US (2) US4123533A (pl)
JP (1) JPS5297996A (pl)
AR (1) AR220675A1 (pl)
AT (1) AT357539B (pl)
AU (1) AU512470B2 (pl)
BE (1) BE851346A (pl)
BG (1) BG29723A3 (pl)
CA (1) CA1082699A (pl)
CH (1) CH637651A5 (pl)
CS (1) CS199288B2 (pl)
DD (1) DD131557A5 (pl)
DE (1) DE2705778A1 (pl)
DK (1) DK152431C (pl)
ES (1) ES455800A1 (pl)
FI (1) FI63574C (pl)
FR (1) FR2340945A1 (pl)
GB (1) GB1554370A (pl)
GR (1) GR62466B (pl)
HU (1) HU174693B (pl)
IL (1) IL51388A (pl)
IN (1) IN146173B (pl)
NL (1) NL7701461A (pl)
NO (1) NO146775C (pl)
PL (1) PL109346B1 (pl)
PT (1) PT66184B (pl)
SE (1) SE431334B (pl)
SU (1) SU969165A3 (pl)
YU (1) YU33777A (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
HU185925B (en) * 1977-12-29 1985-04-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing compounds with nitrogen bridge head
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
HU180701B (en) * 1977-12-29 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing pyrido-/1,2-a/pyrimidines containing a carboxylic or ester group on the pirimidimering
HU178496B (en) * 1977-12-29 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity
HU184058B (en) * 1977-12-29 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new compounds with nitrogen bridge head
US4642384A (en) * 1979-03-19 1987-02-10 Riker Laboratories, Inc. Process for the preparation of derivatives of pyrrolidine and piperidine
AT370731B (de) * 1979-05-02 1983-04-25 Chinoin Gyogyszer Es Vegyeszet Verfahren zur herstellung von neuen kondensierten pyrimidin-derivaten sowie von deren optischen antipoden und salzen
HU183408B (en) * 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
AT377586B (de) 1981-06-30 1985-04-10 Erba Farmitalia Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen
ES8406476A1 (es) * 1982-04-29 1984-07-01 Erba Farmitalia Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas.
IL69274A (en) * 1982-08-05 1986-08-31 Erba Farmitalia (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
US5252572A (en) * 1988-02-03 1993-10-12 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same
EP1539762A2 (en) * 2002-06-26 2005-06-15 Bristol-Myers Squibb Company Bicyclic pyrimidinones as coagulation cascade inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3376304A (en) * 1962-03-14 1968-04-02 Mcneilab Inc 2-(r-r1-r2-methyl)-6-r3-6-r4-fulvenes
US3907798A (en) * 1966-06-15 1975-09-23 Sterling Drug Inc Preparation of 4H-pyrido{8 1,2-a{9 pyrimidin-4-ones from cyclic alkylidene 2-pyridylaminomethylenemalonates
AT286990B (de) * 1966-11-02 1971-01-11 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen
US3567719A (en) * 1967-05-17 1971-03-02 Eastman Kodak Co Methods for preparing dyes and novel dye intermediates
US3635956A (en) * 1968-03-01 1972-01-18 Squibb & Sons Inc Benzothiazines related compounds derivatives and salts thereof
FR2187311B1 (pl) * 1972-06-02 1975-06-20 Bouchara Emile
HU168014B (pl) * 1973-03-30 1976-02-28
US3897420A (en) * 1973-06-28 1975-07-29 Squibb & Sons Inc 2-Aminoalkyl-7-substituted-3,3a,4,5,6,7-hexahydro-3-substituted-2H-pyrazolo(4,3-c)pyridines
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
DE2427614A1 (de) * 1974-06-07 1976-01-02 Gruenenthal Chemie Neue pyrrolderivate und verfahren zu ihrer herstellung
US3898224A (en) * 1974-09-09 1975-08-05 Squibb & Sons Inc 1,6,7,8-Tetrahydro-4-oxo-4H-pyrido {8 1,2-A{9 pyrimidine-9-carboalkoxy compounds
US3965100A (en) * 1975-02-26 1976-06-22 E. R. Squibb & Sons, Inc. 2,3-Dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one and its derivatives
US3935197A (en) * 1975-05-16 1976-01-27 E. R. Squibb & Sons, Inc. 2-Styryl-4H-pyrido(1,2-a)pyrimidin-4-ones

Also Published As

Publication number Publication date
PT66184A (pt) 1977-03-01
SE431334B (sv) 1984-01-30
DD131557A5 (de) 1978-07-05
FI63574C (fi) 1983-07-11
CH637651A5 (de) 1983-08-15
FR2340945B1 (pl) 1981-11-27
IL51388A0 (en) 1977-04-29
NL7701461A (nl) 1977-08-16
US4252807A (en) 1981-02-24
JPS5297996A (en) 1977-08-17
ES455800A1 (es) 1978-07-01
AR220675A1 (es) 1980-11-28
BE851346A (fr) 1977-05-31
BG29723A3 (en) 1981-01-15
IL51388A (en) 1981-07-31
PT66184B (pt) 1978-07-11
DE2705778C2 (pl) 1990-11-29
FI63574B (fi) 1983-03-31
NO146775C (no) 1982-12-08
YU33777A (en) 1983-02-28
SE7701375L (sv) 1977-08-13
HU174693B (hu) 1980-03-28
DE2705778A1 (de) 1977-08-18
JPS6228793B2 (pl) 1987-06-23
US4123533A (en) 1978-10-31
FI770453A (pl) 1977-08-13
PL109346B1 (en) 1980-05-31
FR2340945A1 (fr) 1977-09-09
CA1082699A (en) 1980-07-29
AU512470B2 (en) 1980-10-16
SU969165A3 (ru) 1982-10-23
IN146173B (pl) 1979-03-10
DK152431B (da) 1988-02-29
GR62466B (en) 1979-04-13
AT357539B (de) 1980-07-10
NO146775B (no) 1982-08-30
DK59177A (da) 1977-08-13
CS199288B2 (en) 1980-07-31
NO770457L (no) 1977-08-15
AU2217277A (en) 1978-08-17
ATA84277A (de) 1979-12-15
GB1554370A (en) 1979-10-17

Similar Documents

Publication Publication Date Title
DK148711C (da) Analogifremgangsmaade til fremstilling af 1-(3-mercapto-2-methylpropanoyl)-prolyl-aminosyre-derivater, optiske isomere deraf eller farmaceutisk acceptable salte deraf
DK158671C (da) Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamidoaa-cephalosporinderivater eller fysiologisk acceptable salte eller estere deraf.
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK163244C (da) Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf
DK149308C (da) Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK148478A (da) Fremgangsmaade til fremstilling af cycloalkansubstituerede phenyleddikesyrederivater eller farmaceutisk acceptable salte eller estere deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK148904C (da) Analogifremgangsmaade til fremstilling af analgetisk virksomme enkephalin-analoge pentapeptidamider eller farmaceutisk acceptable, ikke-toxiske syreadditionssalte deraf
DK152431C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive, anellerede pyrimidinderivater eller farmaceutisk acceptable salte eller optisk aktive isomere deraf
DK146160C (da) Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-carboxamider eller farmaceutisk acceptable salte deraf med baser
DK149269C (da) Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK144417C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive alfa-(3,4-dimethoxyphenethylaminomethyl)-2-alkoxybenzylalkoholer eller farmaceutisk anvendelige syreadditionssalte deraf
DK408377A (da) Fremgangsmaade til fremstilling af 11-desoxy-11-oxa-omega-tetranor-prostaglandiner af e-raekken eller de enantiomere eller farmaceutisk acceptable salte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK155672C (da) Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte eller optisk aktive isomerer deraf
DK143445C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive substituerede 1,1-diphenyl-3-amino-propanol-forbindelser
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK154431C (da) Analogifremgangsmaade til fremstilling af 10-halogen-e-homoeburnanderivater eller epimere, optisk aktive antipoder eller fysiologisk acceptable syreadditionssalte deraf
DK151254C (da) Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte deraf
DK141068C (da) Analogifremgangsmaade til fremstilling af indolkinolizidinderivater eller salte eller optisk aktive isomerer deraf

Legal Events

Date Code Title Description
PBP Patent lapsed